AngioDynamics Posts 82% Average Surprise, Faces 466% EPS Drop Estimate
AngioDynamics carries a positive earnings surprise indicator of +4.76% and a strong buy rating heading into its fiscal Q3 reporting date. The company has outperformed estimates in each of the trailing four quarters by an average of 82.14% but faces a projected 466.3% year-over-year EPS decline.
1. Fiscal Q3 Outlook
AngioDynamics is set to release its fiscal Q3 results shortly. Analysts assign a strong buy rating and anticipate a positive earnings surprise indicator of +4.76%.
2. Historical Earnings Surprises
The company has beaten consensus earnings estimates in each of the trailing four quarters, delivering an average surprise of 82.14%. This track record underscores consistent operational performance against expectations.
3. Forecasted EPS Decline
Consensus estimates project a 466.3% year-over-year decline in third-quarter EPS, reflecting an expected downturn in profitability for the period. Investors will watch for revenue drivers and margin pressures in the upcoming report.